Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR)
News | Structural Heart
New Data Show Superiority of Abbott's TriClip Device Compared to Medical Therapy for Tricuspid Regurgitation

March 4, 2023 — Abbott announced late-breaking data for the TriClip transcatheter edge-to-edge repair (TEER) system, a ...

Home March 04, 2023
Home
GEHealthcare at ACC23
News | ACC
GE HealthCare to Present Continuum of Care Innovations in Cardiology at ACC.23/WCC

March 4, 2023 — GE HealthCare will present its latest technologies and innovations for use during the critical planning ...

Home March 04, 2023
Home
iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference
News | ACC
Four New Studies Featuring Zio by iRhythm to be Presented at ACC.23/WCC

March 3, 2023 — iRhythm Technologies, Inc. , a leading digital health company focused on creating trusted solutions that ...

Home March 03, 2023
Home
Machine learning can be used to help clinicians with early diagnosis
News | Heart Failure
Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease

March 3, 2023 — Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart ...

Home March 03, 2023
Home
Machine learning can be used to help clinicians with early diagnosis
News | FFR Technologies
CathWorks to Present Outcomes from International Real-World FFRangio Registry to be Presented at ACC 2023

March 3, 2023 —CathWorks announced key events for the company during the annual American College of Cardiology (ACC) ...

Home March 03, 2023
Home
Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more than double a person’s likelihood of developing cardiovascular issues, according to a study being presented at the American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC, taking place March 4-6, 2023, in New Orleans, LA.
News | Coronavirus (COVID-19)
ACC23 Study Finds Long COVID More Than Doubles Risk of Developing New Cardiac Symptoms

March 3, 2023 — Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more ...

Home March 03, 2023
Home
Primary Results from RADIANCE II Trial Published in JAMA and Results of Pooled Analysis from Three RADIANCE Studies Published in JAMA Cardiology
News | Renal Denervation
ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

March 2, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that primary ...

Home March 02, 2023
Home
Philips Ultrasound Compact System 5500 CV adds to Philips’ cardiology portfolio bringing diagnostic quality cardiac imaging to the patient bedside
News | ACC
Philips Showcases Comprehensive Cardiology Portfolio at ACC23

March 2, 2023 — Royal Philips is showcasing enhancements to its cardiology portfolio at the Annual Scientific Session & ...

Home March 02, 2023
Home
February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being generated and clinical trial data released. Here is a look at last month's Top 10.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: A Look at the Hot Topics from February

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

Home March 01, 2023
Home
Single Intra-Myocardial Intervention with Rexlemestrocel-L Reduced Cardiovascular Death, Myocardial Infarction or Stroke Over Mean Follow-Up of 30 Months in High-Risk Patients with Chronic Heart Failure
News | Ventricular Assist Devices (VAD)
DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology

March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today ...

Home March 01, 2023
Home
System Leverages Next Generation DeepOCTÔ Technology and Near Infrared Spectroscopy to Optimize Coronary Stent Placement in the Cardiac Catheterization Lab
News | Cath Lab
SpectraWAVE Secures 510(k) Clearance of HyperVue Intravascular Imaging System

March 1, 2023 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

Home March 01, 2023
Home
33-year-old, low risk of acute coronary syndrome, presents to off-hour ED with acute chest pain
News | Computed Tomography (CT)
Coronary CTA for Acute Chest Pain Emergencies: Single- vs. Dual-Source Scanners

March 1, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), using a ...

Home March 01, 2023
Home
Enterprise-grade digital stethoscope platform brings non-invasive heart disease detection to primary care
News | Artificial Intelligence
Eko Launches SENSORA Cardiac Disease Detection Platform

February 28, 2023 — Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and ...

Home February 28, 2023
Home
The American College of Cardiology Annual Scientific Session & Expo Begins Saturday, Includes Innovative Updates From Smidt Heart Institute Cardiologists, Cardiothoracic Surgeons
News | ACC
ACC Scientific Session 2023 to Feature Smidt Heart Institute Experts

February 28, 2023 — Experts from the Smidt Heart Institute at Cedars-Sinai, California’s premier cardiology and heart ...

Home February 28, 2023
Home
The FDA is encouraging you to report adverse events related to Trifecta valves to the FDA.
News | Heart Valve Technology
FDA Issues Statement on Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration

February 28, 2023 — On Feb. 27, the U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers to ...

Home February 28, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now